87 related articles for article (PubMed ID: 10989725)
1. [Pefloxacin (Abactal): role in treatment of severe surgical infections].
Gel'fand EB
Antibiot Khimioter; 2000; 45(8):48. PubMed ID: 10989725
[No Abstract] [Full Text] [Related]
2. [Pefloxacin (Abactal): role in modern therapy of bacterial infections].
Fomina IP; Smirnova LB
Antibiot Khimioter; 2000; 45(8):42-7. PubMed ID: 10989724
[No Abstract] [Full Text] [Related]
3. [Effectiveness of pefloxacin in the surgical clinic].
Iakovlev VP; Blatun LA; Khlebnikov EP; Elagina LV; Puchkova LS
Antibiot Khimioter; 1995 Aug; 40(8):43-5. PubMed ID: 8713438
[TBL] [Abstract][Full Text] [Related]
4. [Pefloxacin (Abaktal)--efficacy in treating severe infections, optimization of treatment based on pharmacokinetic and pharmacodynamic parameters].
Budanov SV; Vasil'ev AN; Smirnov LB
Antibiot Khimioter; 2002; 47(12):31-6. PubMed ID: 12728632
[No Abstract] [Full Text] [Related]
5. [Pefloxacin (abactal) efficacy in severe pneumonia].
Aleksanian LA
Antibiot Khimioter; 2001; 46(4):19-21. PubMed ID: 11550502
[No Abstract] [Full Text] [Related]
6. [Antimicrobial activity of pefloxacin in comparison with other quinolones].
Darenkov AF; Kotliarova GA; Kondrat'eva EM
Antibiot Khimioter; 1991 Nov; 36(11):24-6. PubMed ID: 1793290
[TBL] [Abstract][Full Text] [Related]
7. [The administration of peflocine (pefloxacin) in the treatment and prevention of surgical infections].
Saenko VF; Golopykho LI; Belianskiĭ LS; Novopol'tseva IIu
Klin Khir; 1997; (7-8):13-4. PubMed ID: 9518087
[TBL] [Abstract][Full Text] [Related]
8. [Efficacy of pefoxacin (abactal) in the complex treatment of patients with pancreonecrosis].
Gel'fand BR; Burnevich SZ; Gel'fand EB; Tsydenzhapov ETs; Briukhov AN; Brazhnik TB; Saganov VP; Pukhaev DA
Antibiot Khimioter; 2001; 46(5):24-7. PubMed ID: 11558450
[TBL] [Abstract][Full Text] [Related]
9. [Pefloxacin in the treatment of severe infections in intensive care].
Gritti G; Capuzzo M; Verri M; Nepoti ML; Nardini A
Minerva Anestesiol; 1988 Sep; 54(9):367-72. PubMed ID: 3249624
[No Abstract] [Full Text] [Related]
10. [Pefloxacin mesylate--clinical effectiveness in various forms of infectious-inflammatory diseases].
Pozdniakova VP; Nestetrova LIa; Smirnova LB; Iakovlev VP; Blatun LA; Koshil' OI; Fedorov SM; Bakalova LA; Strachunskiĭ LS; Kurmanova KB
Antibiot Khimioter; 1997; 42(7):20-3. PubMed ID: 9334143
[TBL] [Abstract][Full Text] [Related]
11. [Pharmacokinetic basis for the use of pefloxacin in severe forms of infectious-inflammatory diseases].
Navashin PS; Smirnova LB
Antibiot Khimioter; 1998; 43(12):30-8. PubMed ID: 10079873
[No Abstract] [Full Text] [Related]
12. Efficacy of pefloxacin in the treatment of postoperative sepsis in gynaecology.
Arowojolu AO; Bakare RA; Oni AA; Ayodele AE; Kayode OO
Afr J Med Med Sci; 1999; 28(3-4):151-3. PubMed ID: 11205820
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of the effectiveness of the use of pefloxacin in combined radiation-thermal injury].
Makarov GF; Budagov RS; Moiseeva LA; Boldueva NG
Antibiot Khimioter; 1995 Aug; 40(8):36-9. PubMed ID: 8713436
[TBL] [Abstract][Full Text] [Related]
14. [Infection prophylaxis in open leg fractures. Comparison of a dose of pefloxacin and 5 days of cefazolin-oxacillin. A randomized study of 616 cases].
Gagey O; Doyon F; Dellamonica P; Carsenti-Etesse H; Desplaces N; Tancrède C; Evrard J
Rev Chir Orthop Reparatrice Appar Mot; 1999 Jul; 85(4):328-36. PubMed ID: 10457551
[TBL] [Abstract][Full Text] [Related]
15. [The pharmacodynamics and pharmacokinetics of fluoroquinolones in the evaluation of antibacterial therapy regimens].
Smirnova LB; Sokolova VI
Antibiot Khimioter; 2000; 45(7):14-6. PubMed ID: 10987102
[TBL] [Abstract][Full Text] [Related]
16. [Use of pefloxacin in the treatment of infected burn wounds].
Iakovlev VP; Alekseev AA; Krutikov MG; Grishina IA; Izotova GN
Antibiot Khimioter; 1996 Jun; 41(6):39-43. PubMed ID: 9054328
[TBL] [Abstract][Full Text] [Related]
17. [Use of pefloxacin in the treatment of patients with purulent wounds of soft tissues].
Blatun LA; Puchkova LS; Navashin PS; Iakovlev VP; Svetykhin AM
Antibiot Khimioter; 1999; 44(1):20-2. PubMed ID: 10095920
[TBL] [Abstract][Full Text] [Related]
18. Pefloxacin in the treatment of acute severe infections in hospitalized patients. Clinical and bacteriological evaluation.
Giustina A; Romanelli G; Cravarezza P; Ravizzola G; Turano A
J Chemother; 1989 Jul; 1(4 Suppl):668-9. PubMed ID: 16312584
[No Abstract] [Full Text] [Related]
19. [Effect of pefloxacin on immune response].
Artsimovich NG; Nastoiashchaia NN; Navashin PS
Antibiot Khimioter; 2001; 46(4):11-2. PubMed ID: 11550499
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of pefloxacin activity against recent clinical isolates.
Lembo M; Covelli B; Nani E; Lavitola A
J Chemother; 1991 Jan; 3 Suppl 1():51-3. PubMed ID: 12041785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
